CIK 0001740279
- Non-accelerated filer
- Smaller reporting company
- Emerging growth company
IN8BIO, INC.
Sign in to watch- Ticker
- INAB
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 825462585
- Phone
- +1 646-600-6438
- Business address
- EMPIRE STATE BUILDING, 350 5TH AVENUE, SUITE 5330, NEW YORK, NY, 10118
- Former names
- Incysus Therapeutics, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-08-17 | Kreis Leslie W. Director | Purchase | +38,035 | $1.93 | $73K | 3,612,569 |
| 2022-08-17 | Kreis Leslie W. Director | Purchase | +5,823 | $1.93 | $11K | 553,110 |
| 2022-08-17 | Fletcher Aaron G.L. Director | Purchase | +6,142 | $1.93 | $12K | 583,407 |
| 2022-08-17 | Fletcher Aaron G.L. Director | Purchase | +38,035 | $1.93 | $73K | 3,612,569 |
| 2022-08-17 | Fletcher Aaron G.L. Director | Purchase | +5,823 | $1.93 | $11K | 553,110 |
| 2022-08-16 | FAIRBAIRN EMILY Director | Purchase | +789,473 | $1.90 | $1.5M | 4,111,958 |
| 2022-08-16 | Ho William Tai-Wei President, CEO and CFO | Purchase | +26,315 | $1.90 | $50K | 2,315,745 |
| 2022-08-16 | Rochlin Kate Chief Operating Officer | Purchase | +5,263 | $1.90 | $10K | 5,263 |
| 2022-08-16 | McCall Patrick Chief Financial Officer | Purchase | +5,263 | $1.90 | $10K | 5,263 |
| 2022-08-16 | Goswami Trishna Chief Medical Officer | Purchase | +2,631 | $1.90 | $5K | 2,631 |
| 2022-08-16 | Lamb Lawrence EVP and CSO | Purchase | +526 | $1.90 | $999 | 99,730 |
| 2022-08-16 | Greenwood Luba Director | Purchase | +526 | $1.90 | $999 | 7,826 |
| 2022-08-16 | Roemer Alan S. Director | Purchase | +26,315 | $1.90 | $50K | 55,989 |
| 2022-08-16 | Brandt Peter C. Director | Purchase | +105,263 | $1.90 | $200K | 182,473 |
| 2022-08-16 | Kreis Leslie W. Director | Purchase | +217,891 | $1.90 | $414K | 217,891 |
| 2022-08-16 | Kreis Leslie W. Director | Purchase | +1,349,218 | $1.90 | $2.6M | 3,574,534 |
| 2022-08-16 | Kreis Leslie W. Director | Purchase | +206,575 | $1.90 | $392K | 540,287 |
| 2022-08-16 | Fletcher Aaron G.L. Director | Purchase | +217,891 | $1.90 | $414K | 217,891 |
| 2022-08-16 | Fletcher Aaron G.L. Director | Purchase | +1,349,218 | $1.90 | $2.6M | 3,574,534 |
| 2022-08-16 | Fletcher Aaron G.L. Director | Purchase | +206,575 | $1.90 | $392K | 540,287 |
Page 12 of 16 · 309 trades